ammonium hydroxide has been researched along with lactulose in 152 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 59 (38.82) | 18.7374 |
1990's | 22 (14.47) | 18.2507 |
2000's | 20 (13.16) | 29.6817 |
2010's | 40 (26.32) | 24.3611 |
2020's | 11 (7.24) | 2.80 |
Authors | Studies |
---|---|
Conn, HO; Leevy, CM; Levy, LL; Maddrey, WC; Rodgers, JB; Seeff, L; Vlahcevic, ZR | 1 |
Killingley, M; Vince, A; Wrong, OM | 1 |
Conn, HO | 1 |
Hicks, EP; Hislop, IG; Ratnaike, RN | 1 |
Demeulenaere, L; van Egmond, J; Van Waes, L | 1 |
Leonhardt, H; Sanhueza, P | 1 |
Bakker, HD; Brink, M; de Bree, PK; Desplanque, J; van der Heiden, C; Wadman, SK | 1 |
Glasgow, AM; Kraegel, JH; Schulman, JD | 1 |
Mikesell, D; Smith, VS; Stoker, JA | 1 |
Imler, M | 2 |
Müting, D | 2 |
Kosman, ME | 1 |
Maddrey, WC; Weber, FL | 1 |
Martini, GA | 1 |
Bergonzi, P; Bianco, S; Borzone, A; Butti, A; Cagossi, M; Civello, IM; Nanni, G; Pigliucci, GM | 1 |
Frick, A; Imler, M; Lavillaureix, L; Peter, B; Reeb, E; Schlienger, JL; Stahl, J | 1 |
Ferrari, A; Manenti, F | 1 |
Altamura, M; Altomare, E; Cirelli, F; De Vincentiis, A; Palasciano, G; Vendemiale, G | 1 |
Mortensen, PB | 1 |
Mullen, KD; Weber, FL | 1 |
Hong, RW; Rodrick, ML; Rounds, JD; van Leeuwen, PA; Wilmore, D | 1 |
Hayashi, K; Ikeda, T; Ito, T; Karube, H; Mizuno, T; Nomoto, T; Okada, T; Sakurai, A; Shindo, K; Tarao, K | 1 |
Kanetake, Y; Kubota, K; Matsuoka, Y; Mizukami, A; Sunagane, N; Uruno, T; Yamada, M | 1 |
Bobrowska, E; Boroń, P; Flisiak, R; Kaczmarska, A; Nowak, HF; Szpakowicz, T; Zimnoch, L | 1 |
McNeil, NI; Vince, AJ; Wager, JD; Wrong, OM | 1 |
Obayashi, C; Onishi, S; Suzuki, Y; Yamazaki, H | 1 |
Ceschia, T; Colle, R | 1 |
Demigné, C; Rémésy, C | 1 |
Stephen, AM | 1 |
Jensen, DM | 1 |
Bouman, AA; Douwes, AC; Jakobs, C; Kneepkens, CM; van der Burg, GJ; van der Klei-van Moorsel, JM | 1 |
Vince, AJ; Wrong, OM | 1 |
Herrmann, R; Weber, FL | 1 |
Arieff, AI; Fraser, CL | 1 |
Soeters, PB; van Berlo, CL; van Leeuwen, PA | 1 |
Janssen, DA; Kalayoglu, M; Sollinger, HW | 1 |
Schafer, DF | 1 |
Banwell, JG; Cummings, JH; Fresard, KM; Weber, FL | 1 |
Palmieri, V; Tardi, S; Ventrella, F | 1 |
Soeters, PB; van Leeuwen, PA | 1 |
Lanthier, PL; Morgan, MY | 1 |
Haerting, J; Mantel, E; Nilius, R; Rink, C | 1 |
Fischer, JE | 1 |
Devos, J; Guffens, JM; Pirotte, J | 1 |
Bell, B; Jacobson, S | 1 |
Williams, R | 1 |
Breen, KJ; Hoyumpa, AM; Schenker, S | 1 |
Frexinos, J; Germain, L; Louis, A; Ribet, A | 2 |
Girard, PF; Kopp, N; Trillet, M | 1 |
Walker, FA | 1 |
Conn, HO; Fessel, JM | 1 |
Drueke, T; Jungers, P; Man, NK; Monteverde, CE; Nucete, MR; Paris, J; Zingraff, J | 1 |
Boonstra, S; Gips, CH; Qué, GS; Van Der Zwan, JC | 1 |
Misra, P | 1 |
Hirasawa, T; Saheki, T; Yajima, Y | 1 |
Altilia, F; Amadio, R; Cipollini, F | 1 |
Crossley, IR; Williams, R | 1 |
Blok, IuE; Loginov, AS | 1 |
Beaven, J; Bjørneklett, A; Blomhoff, JP; Jenssen, E; Skrede, S | 1 |
Cangiano, C; Cascino, A; De Conciliis, D; Giunchi, G; Merli, M; Riggio, O; Rossi-Fanelli, F; Stortoni, M | 1 |
Fresard, KM; Lally, BR; Weber, FL | 1 |
Weber, FL | 3 |
Maddison, JE | 1 |
Burridge, SM; Vince, AJ | 1 |
Müting, D; Reikowski, J; Rosskopf, U | 1 |
Ferrieri, A; Massimetti, A; Puxeddu, A; Quartini, M | 1 |
Hirata, Y; Kimura, K; Ozaki, T; Sato, S; Suzuki, K; Watanabe, M; Yoshikuni, Y | 1 |
Hirata, Y; Kimura, K; Niida, H; Ozaki, T; Ueda, F; Watanabe, M; Yamamoto, O; Yoshikuni, Y | 1 |
Hirata, Y; Kimura, K; Ozaki, T; Watanabe, M; Yoshikuni, Y | 1 |
Blendis, LM; Fernandes, J; Jenkins, DJ; Koo, M; Morali, G; Rao, AV; Wolever, TM | 1 |
Dölle, W; Fürst, P; Graser, TA; Hartmann, F; Nöldeke, IL; Plauth, M; Raible, A | 1 |
Abbiati, R; Coltorti, M; Del Vecchio Blanco, C; Loguercio, C; Rinaldi, M; Romano, A | 1 |
Eisenburg, J | 1 |
Katz, R; Rose, E; Winter, SS | 1 |
Arakawa, Y; Fujiyama, S; Imai, F; Kawasaki, H; Kobayashi, K; Muto, Y; Ohto, M; Okita, K; Sakai, T; Sato, S; Shimada, S; Tanikawa, K; Toda, G; Tsujii, T; Watanabe, A | 1 |
Attili, AF; Hassan, C; Meddi, P; Rinaldi, V; Winn, S; Zullo, A | 1 |
Takeuchi, H | 2 |
Marquart, B; Pietrzak, T; Zentek, J | 1 |
Juśkiewicz, J; Zduńczyk, Z | 1 |
Dai, SJ; Li, YY; Nie, YQ; Ping, L; Sha, WH; Zeng, Z | 1 |
Solga, SF | 1 |
Li, YY; Zeng, Z | 1 |
Maruyama, K; Shirakura, K | 1 |
Dasarathy, S | 1 |
Bongaerts, G; Severijnen, R; Timmerman, H | 1 |
Jia, L; Zhang, MH | 1 |
Choi, SK; Joo, YE; Kim, HS; Kim, SJ; Park, CH; Rew, JS | 1 |
Awati, A; Bosch, MW; Li, YC; Verstegen, MW; Williams, BA | 1 |
Hendriks, ME; Portegies, P; van Westerloo, DJ | 1 |
Puri, V; Sarin, SK; Sharma, BC; Sharma, P | 1 |
Demetter, P; Devière, J; Goffin, P; Gustot, T; Hols, P; Moreno, C; Nicaise, C; Prozzi, D; Quertinmont, E; Suain, V; Viaene, E | 1 |
Sarin, SK; Sharma, BC; Sharma, P | 1 |
Shaikh, OS; Sundaram, V | 1 |
Galvano, F; Gargante, MP; Li Volti, G; Malaguarnera, G; Malaguarnera, M; Mastrojeni, S; Pennisi, G; Rampello, L; Salmeri, M | 1 |
Riordan, SM; Williams, R | 1 |
Mullen, KD; Prakash, R | 1 |
Mittal, VV; Sarin, SK; Sharma, BC; Sharma, P | 1 |
Cao, WK; Li, L; Lu, CZ; Luo, M | 1 |
Khungar, V; Poordad, F | 2 |
Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B | 1 |
Agrawal, A; Sarin, SK; Sharma, BC; Sharma, P | 1 |
Häussinger, D; Kircheis, G | 1 |
Halpin, LE; Yamamoto, BK | 1 |
Jain, L; Puri, SK; Sarin, S; Sharma, BC; Sharma, P; Srivastava, S | 1 |
Liang, H; Liu, Q; Peng, L; Song, J; Tong, M; Wen, J | 1 |
Ivnitsky, JJ; Krasnov, KA; Rejniuk, VL; Schäfer, TV | 1 |
Halpin, LE; Northrop, NA; Yamamoto, BK | 2 |
El Yamany, SA; Hamisa, MF; Hasan, AM; Soliman, HH; Ziada, DH | 1 |
Jalan, R; Jover-Cobos, M; Khetan, V | 1 |
Fukada, K; Hazama, T; Hirozawa, D; Hoshi, T; Sawada, J; Yaegaki, T | 1 |
Hadjihambi, A; Jalan, R; Khetan, V | 1 |
Lu, L; Patel, A; Sheasgreen, C | 1 |
Chawla, R; Jindal, A; Maharshi, S; Sachdeva, S; Sharma, BC; Srivastava, S | 1 |
Lewicki, R; Mudalel, ML; Munier, JJ; Risby, TH; Solga, SF; Spacek, LA; Stoltzfus, J; Tittel, FK | 1 |
Utzt, MJ | 1 |
Sussman, NL | 1 |
Kodali, S; McGuire, BM | 1 |
Aydin, M; Evlice, B; Ferguson, M; Özen, ME; Uzel, İ | 1 |
Ampuero, J; Bellot, P; Figueruela, B; Francés, R; Gallego-Durán, R; González-Navajas, JM; Martínez-Moreno, B; Moratalla, A; Roger, M; Romero-Gómez, M; Such, J; Zapater, P | 1 |
Morgan, MY | 1 |
Mantri, AK; Sangam, A; Sarin, SK; Sharma, BC; Singh, J; Srivastava, S; Trehanpati, N | 1 |
Puri, V; Sachdeva, S; Sharma, BC; Singh, J; Srivastava, S | 1 |
Cámara-Lemarroy, CR; Delgado-García, G; Estrada-Bellmann, I; García-Valadez, E; Monreal-Robles, R | 1 |
Bellmann, S; Berressem, D; Bothe, MK; Gaigg, B; Koehler, A; Kuchinka-Koch, A; Maathuis, AJH; Schwejda-Guettes, S; Stover, JF; van der Vossen, JMBM | 1 |
Arias, N; Hadjihambi, A; Jalan, R; Sheikh, M | 1 |
Céspedes, IC; de Andrade, JS; de Barros Viana, M; Le Sueur-Maluf, L; Mariotti, FFN; Mendes, NF; Nagaoka, MR | 1 |
Chung, HJ; Hong, ST; Kim, HJ; Liu, J; Lkhagva, E | 1 |
Cai, XJ; Hu, CM; Wang, L | 1 |
Alsahhar, JS; Rahimi, RS | 1 |
Boutros, S; Saab, S; Winters, A; Yanny, B | 1 |
Haj, M; Rockey, DC | 1 |
Alves, JI; Amorim, C; Cardoso, BB; Pereira, MA; Rodrigues, LR; Silvério, SC | 1 |
Albitar, HAH; Cho, J; Liu, M; Pajot, G; Ravi, K; Shah, PA | 1 |
Cutler, NS; MacGregor, DA; Sadowski, BW | 1 |
Dalal, A; Jain, A; Kumar, A; Mahajan, B; Sachdeva, S; Sharma, BC; Sonika, U; Srivastava, S | 1 |
Ahmed, A; Ata, F; Gaber, M; Hashim, A; Mahfouz, A; Musa, S; Petkar, M; Schirmacher, P | 1 |
Hayakawa, Y; Higuchi, M; Inada, K; Ishido, S; Izumi, N; Kakegawa, T; Kaneko, S; Kirino, S; Kurosaki, M; Maeyashiki, C; Matsumoto, H; Nakanishi, H; Nobusawa, T; Okamoto, R; Takahashi, Y; Takaura, K; Tamaki, N; Tanaka, S; Tanaka, Y; Tsuchiya, K; Yamashita, K; Yasui, Y | 1 |
Błońska, A; Chojnacki, C; Chojnacki, M; Konrad, P; Mędrek-Socha, M | 1 |
Djernes, L; Eriksen, PL; Ott, P; Vilstrup, H | 1 |
Li, F; Shi, J | 1 |
Amodio, P; Shawcross, DL; Thabut, D | 1 |
34 review(s) available for ammonium hydroxide and lactulose
Article | Year |
---|---|
Role of nutrition in hepatic encephalopathy.
Topics: Ammonia; Diet; Diet Therapy; Dietary Proteins; Enteral Nutrition; Fatty Acids, Nonesterified; Hepatic Encephalopathy; Humans; Lactulose; Nutrition Disorders; Parenteral Nutrition; Tryptophan | 1991 |
Hepatic encephalopathy.
Topics: Ammonia; Animals; Blood-Brain Barrier; Brain; Demyelinating Diseases; Fatty Acids; Glutamine; Hepatic Encephalopathy; Humans; Hypernatremia; Hyponatremia; Ketoglutaric Acids; Lactulose; Methionine; Neomycin; Pons; Synaptic Transmission; Tryptophan | 1985 |
Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment.
Topics: Acute Disease; Amino Acids; Ammonia; Brain; Chronic Disease; Colon; Dietary Proteins; Fatty Acids; Glutamine; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Neomycin; Neurotransmitter Agents; Portacaval Shunt, Surgical; Postoperative Complications; Sterilization; Urease | 1974 |
Recognition and management of acute and chronic hepatic encephalopathy.
Topics: Acute Disease; Amines; Ammonia; Animals; Brain Edema; Central Nervous System; Chronic Disease; Diet Therapy; Dihydroxyphenylalanine; Exchange Transfusion, Whole Blood; Fatty Acids, Volatile; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Renal Dialysis | 1973 |
Hepatic encephalopathy: current status.
Topics: Adrenal Cortex Hormones; Amino Acids; Ammonia; Animals; Anti-Bacterial Agents; Biogenic Amines; Dihydroxyphenylalanine; Diuretics; Energy Metabolism; Exchange Transfusion, Whole Blood; Fatty Acids; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Intestines; Lactulose; Liver Diseases; Neurologic Manifestations; Oxygen Consumption; Portacaval Shunt, Surgical | 1974 |
[Emergency treatment of hepatic coma and porto-caval encephalopathy].
Topics: Acidosis; Alkalosis; Ammonia; Anti-Bacterial Agents; Brain Diseases; Diuretics; Emergencies; Glucose; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis | 1973 |
[Dietary problems in the treatment of portal hypertension with special reference to portacaval shunt].
Topics: Adult; Ammonia; Animals; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Male; Middle Aged; Milk; Phenols; Portacaval Shunt, Surgical; Postoperative Care; Potassium; Sodium; Vitamins | 1974 |
[Therapy of hepatic encephalopathy. Personal experience and a review of the literature].
Topics: Amino Acids; Ammonia; Bromocriptine; Electroencephalography; Fatty Acids; Hepatic Encephalopathy; Lactulose; Levodopa; Neomycin; Nervous System; Neurologic Examination; Neurotransmitter Agents; Sulfhydryl Compounds; Synaptic Transmission | 1982 |
Progress in the treatment of chronic portasystemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin | 1984 |
[Hepatic minimal encephalopathy. The most frequently overlooked, clinically occult "metabolic syndrome" on the cirrhosis patient].
Topics: Ammonia; Arginine; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Neuropsychological Tests; Prognosis; Psychometrics | 1996 |
Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora.
Topics: Ammonia; Anti-Bacterial Agents; Bacteria; Cathartics; Dietary Fiber; Drug Synergism; Feces; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intestines; Lactulose; Liver; Neomycin; Neurotoxins; Nitrogen; Urea | 1996 |
Effects of lactulose on nitrogen metabolism.
Topics: Ammonia; Animals; Anti-Bacterial Agents; Colon; Dietary Fiber; Feces; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Nitrogen; Urea | 1997 |
[Chronic acquired(non-Wilsonian) hepatocerebral degeneration(CAHD)].
Topics: Amino Acids, Branched-Chain; Ammonia; Chronic Disease; Hepatolenticular Degeneration; Humans; Lactulose; Liver Diseases; Prognosis | 2000 |
[Hepatic encephalopathy].
Topics: Alcoholism; Amino Acids, Branched-Chain; Ammonia; Blood-Brain Barrier; Embolization, Therapeutic; Hepatic Encephalopathy; Humans; Lactulose; Magnetic Resonance Imaging; Neurotransmitter Agents; Phenols; Psychometrics; Receptors, Neurotransmitter; Severity of Illness Index; Sulfhydryl Compounds | 2003 |
[Chronic acquired hepatocerebral degeneration].
Topics: Amino Acids, Branched-Chain; Ammonia; Astrocytes; Basal Ganglia; Brain; Chronic Disease; Dementia; Diagnosis, Differential; Diagnostic Imaging; Hepatolenticular Degeneration; Humans; Lactulose; Manganese | 2004 |
Role of gut bacteria in the therapy of hepatic encephalopathy with lactulose and antibiotics.
Topics: Ammonia; Anti-Bacterial Agents; Bacteria; Dietary Fiber; Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intestines; Lactulose; Sodium Benzoate | 2003 |
Hepatic encephalopathy: pathophysiology and emerging therapies.
Topics: Ammonia; Anti-Infective Agents; Drug Therapy, Combination; Dyskinesias; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver; Liver Cirrhosis; Liver, Artificial; Manganese; Metronidazole; Neomycin; Neuropsychological Tests; Portasystemic Shunt, Transjugular Intrahepatic; Protein-Energy Malnutrition; Recurrence; Rifamycins; Rifaximin; Trace Elements; Zinc | 2009 |
Mechanisms, diagnosis and management of hepatic encephalopathy.
Topics: Ammonia; Gastrointestinal Agents; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Lactulose; Neuropsychological Tests; Rifamycins; Rifaximin | 2010 |
Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.
Topics: Adult; Ammonia; Diarrhea; Disease Progression; Hepatic Encephalopathy; Humans; Lactulose; Neuropsychological Tests; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2011 |
Management of overt hepatic encephalopathy.
Topics: Acarbose; Ammonia; Disease Management; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin | 2012 |
[Hepatic encephalopathy and liver transplantation].
Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2012 |
Hepatic encephalopathy.
Topics: Ammonia; Anti-Bacterial Agents; Antidotes; Charcoal; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Prebiotics; Probiotics; Rifamycins; Rifaximin | 2012 |
[Hepatic encephalopathy].
Topics: Amino Acids, Branched-Chain; Ammonia; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Automobile Driving; Brain; Diet, Protein-Restricted; Disability Evaluation; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Ibuprofen; Indomethacin; Lactulose; Nerve Net; Neuroglia; Neurologic Examination; Neuronal Plasticity; Neuropsychological Tests; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Probiotics; Prognosis; Rifamycins; Rifaximin | 2012 |
Treatment of hyperammonemia in liver failure.
Topics: Ammonia; Brain; Glycerol; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Phenylbutyrates; Probiotics; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin | 2014 |
Pharmacotherapy for hyperammonemia.
Topics: Ammonia; Animals; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Rifamycins; Rifaximin; Sorption Detoxification | 2014 |
Pathophysiology, diagnosis, and management of hepatic encephalopathy.
Topics: Ammonia; Anti-Bacterial Agents; Anti-Inflammatory Agents; Hepatic Encephalopathy; Humans; Inflammation; Lactulose; Liver Cirrhosis | 2014 |
Treatment of Overt Hepatic Encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Arteriovenous Fistula; Dipeptides; Gastrointestinal Agents; Glycerol; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure; Malnutrition; Ornithine; Phenylbutyrates; Probiotics; Rifamycins; Rifaximin | 2015 |
Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure.
Topics: Acetylcysteine; Ammonia; Brain Edema; Free Radical Scavengers; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intracranial Pressure; Lactulose; Liver Failure, Acute; Neuroimaging; Neuropsychological Tests; Nutritional Support; Rifamycins; Rifaximin | 2015 |
Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
Topics: Ammonia; Animals; Disaccharides; Gastrointestinal Agents; Health Knowledge, Attitudes, Practice; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Randomized Controlled Trials as Topic; Sugar Alcohols | 2016 |
Hepatic encephalopathy: a critical current review.
Topics: Albumins; Ammonia; Anti-Bacterial Agents; Bile Acids and Salts; Brain; Brain Edema; Cognitive Dysfunction; Dipeptides; Energy Metabolism; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Portasystemic Shunt, Surgical; Prognosis; Psychometrics; Severity of Illness Index; Synaptic Transmission | 2018 |
The Pharmabiotic Approach to Treat Hyperammonemia.
Topics: Ammonia; Animals; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease Models, Animal; Gastrointestinal Agents; Gastrointestinal Microbiome; Humans; Hyperammonemia; Lactulose; Liver; Probiotics; Randomized Controlled Trials as Topic; Synbiotics | 2018 |
Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Ammonia; Dipeptides; Fecal Microbiota Transplantation; Frailty; Gastrointestinal Agents; Gastrointestinal Microbiome; Glycerol; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Ornithine; Phenylbutyrates; Polyethylene Glycols; Probiotics; Rifaximin; Trace Elements; Zinc | 2019 |
Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach.
Topics: Amino Acids, Branched-Chain; Ammonia; Caregivers; Cost of Illness; Dipeptides; Embolization, Therapeutic; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Neomycin; Patient Readmission; Rifaximin; Severity of Illness Index; Sodium Benzoate; Sorption Detoxification; Zinc | 2019 |
Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review.
Topics: Adult; Ammonia; Carcinoma, Hepatocellular; Humans; Lactulose; Liver Neoplasms; Male; Ornithine Carbamoyltransferase Deficiency Disease | 2022 |
27 trial(s) available for ammonium hydroxide and lactulose
Article | Year |
---|---|
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
Topics: Aged; Ammonia; Blood; Chronic Disease; Clinical Trials as Topic; Disaccharides; Electroencephalography; Feces; Female; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Male; Mental Processes; Middle Aged; Neomycin; Prospective Studies; Sorbitol; Trail Making Test | 1977 |
[Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
Topics: Ammonia; Dietary Proteins; Disaccharides; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Phenols; Portacaval Shunt, Surgical | 1978 |
Crystalline lactulose in the therapy of hepatic cirrhosis. Evaluation of clinical and immunological parameters. Preliminary results.
Topics: Adult; Aged; Ammonia; Bilirubin; Blood Bactericidal Activity; Crystallization; Female; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Suspensions | 1992 |
Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.
Topics: Ammonia; Bacteria; Disaccharides; Double-Blind Method; Drug Resistance; Electroencephalography; Feces; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Randomized Controlled Trials as Topic; Vancomycin | 1990 |
[Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
Topics: Adult; Aged; Ammonia; Brain Diseases; Chronic Disease; Clinical Trials as Topic; Disaccharides; Electroencephalography; Female; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neurologic Manifestations; Placebos; Portacaval Shunt, Surgical | 1973 |
[Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
Topics: Adult; Aged; Ammonia; Brain Diseases; Chronic Disease; Clinical Trials as Topic; Disaccharides; Electroencephalography; Female; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neurologic Manifestations; Placebos; Portacaval Shunt, Surgical | 1973 |
Progress in the treatment of chronic portasystemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin | 1984 |
Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study.
Topics: Amino Acids; Amino Acids, Branched-Chain; Ammonia; Clinical Trials as Topic; Disaccharides; Glucose; Hepatic Encephalopathy; Humans; Infusions, Parenteral; Lactulose; Liver Cirrhosis | 1982 |
Therapy of portal-systemic encephalopathy: the practical and the promising.
Topics: Amino Acids; Ammonia; Bacteria; Enema; Hepatic Encephalopathy; Humans; Intestines; Lactulose; Neomycin | 1981 |
Rifaximin in the treatment of chronic hepatic encephalopathy.
Topics: Adult; Aged; Aged, 80 and over; Ammonia; Analysis of Variance; Anti-Bacterial Agents; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Rifamycins; Rifaximin; Time Factors; Treatment Outcome | 1995 |
Effect of acute lactulose administration on serum acetate levels in cirrhosis.
Topics: Acetates; Adult; Aged; Ammonia; Blood Glucose; Colon; Cross-Over Studies; Diet; Fatty Acids, Nonesterified; Female; Fermentation; Humans; Hydrogen; Insulin; Lactulose; Liver Cirrhosis; Male; Middle Aged; Respiration | 1994 |
Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy.
Topics: Adult; Aged; Ammonia; Dose-Response Relationship, Drug; Double-Blind Method; Enterococcus faecium; Evoked Potentials, Visual; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Severity of Illness Index; Time Factors | 1995 |
Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy.
Topics: Administration, Oral; Adult; Aged; Ammonia; Cathartics; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Wechsler Scales | 1997 |
[Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy].
Topics: Adult; Aged; Ammonia; Evoked Potentials, Somatosensory; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intelligence Tests; Lactulose; Male; Middle Aged; Treatment Outcome | 2003 |
[Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
Topics: Administration, Oral; Adult; Aged; Ammonia; Evoked Potentials, Somatosensory; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Function Tests; Male; Middle Aged; Quality of Life; Time Factors; Treatment Outcome | 2003 |
An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
Topics: Adult; Ammonia; Drug Therapy, Combination; Event-Related Potentials, P300; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Neuropsychological Tests; Probiotics; Psychometrics; Severity of Illness Index; Treatment Outcome | 2008 |
Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy.
Topics: Adult; Ammonia; Bifidobacterium; Cognition; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Neuropsychological Tests; Oligosaccharides; Prebiotics; Probiotics; Psychometrics; Time Factors; Treatment Outcome | 2010 |
A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
Topics: Adult; Ammonia; Dipeptides; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Neuropsychological Tests; Probiotics; Psychometrics; Quality of Life; Severity of Illness Index; Treatment Outcome | 2011 |
Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Topics: Adolescent; Adult; Aged; Ammonia; Analysis of Variance; Chi-Square Distribution; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Probiotics; Psychometrics; Secondary Prevention; Statistics, Nonparametric; Treatment Outcome | 2012 |
Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Topics: Adolescent; Adult; Aged; Ammonia; Biomarkers; Endotoxins; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Inflammation Mediators; Interleukin-18; Interleukin-6; Lactulose; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Tumor Necrosis Factor-alpha; Young Adult | 2013 |
Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Topics: Adult; Aged; Ammonia; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Treatment Outcome | 2013 |
Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
Topics: Adult; Ammonia; Brain; Choline; Creatinine; Female; Gastrointestinal Agents; Gastrointestinal Tract; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Inositol; Lactobacillus acidophilus; Lactulose; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Probiotics | 2013 |
Breath ammonia and ethanol increase in response to a high protein challenge.
Topics: Acetone; Adult; Ammonia; Analysis of Variance; Beverages; Breath Tests; Dietary Proteins; Ethanol; Exhalation; Female; Humans; Hydrogen; Lactulose; Male; Respiration; Young Adult | 2015 |
Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy.
Topics: Adult; Albumins; Ammonia; Biomarkers; Drug Therapy, Combination; Endotoxins; Female; Hepatic Encephalopathy; Humans; Interleukin-18; Interleukin-6; Lactulose; Male; Middle Aged; Prospective Studies; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
Topics: Ammonia; Aspartic Acid; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Rifaximin; Tumor Necrosis Factor-alpha | 2022 |
Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia-targeting treatments.
Topics: Ammonia; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Liver Cirrhosis; Male; Phenylbutyrates; Rifaximin | 2023 |
Clinical study of probiotics combined with lactulose for minimal hepatic encephalopathy treatment.
Topics: Ammonia; Glycation End Products, Advanced; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Probiotics | 2023 |
92 other study(ies) available for ammonium hydroxide and lactulose
Article | Year |
---|---|
Effect of lactulose on ammonia production in a fecal incubation system.
Topics: Ammonia; Bacteria; Bacteriological Techniques; Cecum; Disaccharides; Feces; Female; Glucose; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Lactulose; Mannitol; Sorbitol | 1978 |
Lactulose: a drug in search of a modus operandi.
Topics: Ammonia; Colon; Disaccharides; Escherichia coli; Feces; Galactosides; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactobacillus acidophilus; Lactulose | 1978 |
The rectal administration of lactulose.
Topics: Aged; Ammonia; Colon; Disaccharides; Electroencephalography; Enema; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Male; Middle Aged; Sodium Chloride | 1975 |
Emergency treatment of portal-systemic encephalopathy with lactulose enemas. A controlled study.
Topics: Ammonia; Disaccharides; Emergencies; Enema; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male | 1979 |
Attempted dietary treatment of a boy with hyperammonemia due to ornithine transferase deficiency.
Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids; Ammonia; Arginine; Child, Preschool; Citrates; Dietary Proteins; Humans; Lactulose; Male; Ornithine; Ornithine Carbamoyltransferase Deficiency Disease | 1978 |
Studies of the cause and treatment of hyperammonemia in females with ornithine transcarbamylase deficiency.
Topics: Amino Acids, Essential; Ammonia; Child; Dietary Proteins; Female; Heterozygote; Humans; Keto Acids; Lactulose; Liver; Ornithine Carbamoyltransferase Deficiency Disease; X Chromosome | 1978 |
The use of lactulose syrup for the control of hyperammonemia in Reye's syndrome: report of case.
Topics: Ammonia; Child; Disaccharides; Humans; Lactulose; Male; Reye Syndrome | 1978 |
[Present-day therapy of hepatic encephalopathy (author's transl)].
Topics: Acid-Base Imbalance; Ammonia; Anemia; Anti-Bacterial Agents; Exchange Transfusion, Whole Blood; Glucose; Hepatic Encephalopathy; Humans; Hypoxia; Intestinal Mucosa; Ketoglutaric Acids; Kidney; Lactulose; Liver Cirrhosis; Ornithine; Perfusion; Prognosis; Renal Dialysis | 1976 |
[Clinical picture and therapy of portal-systemic encephalopathy (author's transl)].
Topics: Acetates; Acidosis; Alcoholism; Amino Acids; Ammonia; Astrocytes; Dietary Proteins; Diuretics; Hemorrhage; Hepatic Encephalopathy; Humans; Hypokalemia; Lactulose; Liver; Liver Cirrhosis; Neomycin; Potassium; Skin Manifestations; Water-Electrolyte Balance | 1977 |
Lactulose (cephulac) in portosystemic encephalopathy.
Topics: Ammonia; Depression, Chemical; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Recurrence | 1976 |
Chronic hepatic encephalopathy.
Topics: Amino Acids, Essential; Ammonia; Analgesics; Anesthesia; Anti-Bacterial Agents; Biogenic Amines; Chronic Disease; Constipation; Dietary Proteins; Dihydroxyphenylalanine; Diuretics; Fatty Acids; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Hypnotics and Sedatives; Infections; Lactulose; Methionine; Portacaval Shunt, Surgical; Tranquilizing Agents; Uremia | 1975 |
[Psychiatric-neurological disorders in chronic liver diseases].
Topics: Acute Disease; Ammonia; Biotransformation; Brain Damage, Chronic; Brain Diseases; Chronic Disease; Dietary Proteins; Diuretics; Glutamine; Humans; Lactulose; Liver Diseases; Mental Disorders; Portacaval Shunt, Surgical; Postoperative Complications; Prognosis | 1975 |
[Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
Topics: Adult; Aged; Ammonia; Disaccharides; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical | 1975 |
[Intestinal ammoniogenesis in normal rats. Comparative study of the action of antibiotics and lactulose].
Topics: Ammonia; Animals; Anti-Bacterial Agents; Disaccharides; Intestinal Mucosa; Lactulose; Rats | 1975 |
[Therapy of coma in liver cirrhosis].
Topics: Adenosine Triphosphate; Ammonia; Arginine; Brain; Colon; Disaccharides; Hepatic Encephalopathy; Humans; Hydroxamic Acids; Intestinal Absorption; Lactulose; Levodopa; Liver Cirrhosis | 1975 |
The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion.
Topics: Administration, Oral; Adult; Ammonia; Colon; Feces; Female; Humans; Lactates; Lactulose; Male; Middle Aged; Nitrogen | 1992 |
Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin.
Topics: Ammonia; Analysis of Variance; Animals; Cefazolin; Cholestyramine Resin; Endotoxins; Gastrointestinal Contents; Glutamine; Hepatectomy; Hepatic Encephalopathy; Isotonic Solutions; Lactulose; Male; Neomycin; Random Allocation; Rats; Rats, Inbred Strains; Sodium Chloride | 1991 |
[Effects of lactulose on blood ammonia levels in beagles with end-to-side portacaval shunt].
Topics: Administration, Oral; Ammonia; Animals; Dogs; Hydrogen-Ion Concentration; Lactulose; Male; Portacaval Shunt, Surgical | 1990 |
[Effect of differentiated diet therapy on the clinical results and biochemical indicators in chronic hepatic encephalopathy].
Topics: Amino Acids; Amino Acids, Branched-Chain; Ammonia; Brain; Brain Chemistry; Chronic Disease; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Liver | 1990 |
The effect of lactulose, pectin, arabinogalactan and cellulose on the production of organic acids and metabolism of ammonia by intestinal bacteria in a faecal incubation system.
Topics: Adult; Ammonia; Cellulose; Dietary Carbohydrates; Fatty Acids, Volatile; Feces; Galactans; Humans; Hydrogen-Ion Concentration; Lactulose; Middle Aged; Osmolar Concentration; Pectins | 1990 |
[Effect of lactulose on ammonia metabolism during exercise].
Topics: Adult; Ammonia; Blood Pressure; Disaccharides; Exercise; Exercise Test; Heart Rate; Humans; Lactates; Lactic Acid; Lactulose; Male | 1990 |
[Oral bacteriotherapy with Bifidobacterium bifidum and Lactobacillus acidophilus in cirrhotic patients].
Topics: Ammonia; Bifidobacterium; Diarrhea; Humans; Lactobacillus acidophilus; Lactulose; Liver Cirrhosis, Alcoholic; Middle Aged | 1989 |
Specific effects of fermentable carbohydrates on blood urea flux and ammonia absorption in the rat cecum.
Topics: Ammonia; Animals; Cecum; Dietary Carbohydrates; Dietary Fiber; Disaccharides; Fatty Acids, Volatile; Fermentation; Galactans; Intestinal Absorption; Lactulose; Male; Mannans; Organ Size; Pectins; Plant Gums; Polysaccharides; Rats; Rats, Inbred Strains; Starch; Urea | 1989 |
Dietary fibre and colonic nitrogen metabolism.
Topics: Ammonia; Colon; Dietary Carbohydrates; Dietary Fiber; Feces; Humans; Intubation, Gastrointestinal; Lactulose; Nitrogen; Proteins | 1987 |
Portal-systemic encephalopathy and hepatic coma.
Topics: Amino Acids; Ammonia; Dietary Proteins; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Neurotransmitter Agents | 1986 |
Lactitol, lactulose, and blood ammonia.
Topics: Ammonia; Depression, Chemical; Disaccharides; Humans; Lactulose; Sugar Alcohols | 1987 |
Lactitol, lactulose, and blood ammonia.
Topics: Ammonia; Disaccharides; Enterobacteriaceae; Humans; Lactulose; Sugar Alcohols | 1987 |
Lactulose and ammonia.
Topics: Ammonia; Disaccharides; Humans; Lactulose; Liver Diseases; Pectins | 1987 |
Porcine intestinal ammonia liberation. Influence of food intake, lactulose and neomycin treatment.
Topics: Alanine; Amino Acids; Ammonia; Animals; Blood Flow Velocity; Citrulline; Disaccharides; Eating; Female; Glutamates; Glutamine; Intestinal Mucosa; Lactulose; Neomycin; Swine; Urea | 1988 |
Pneumatosis cystoides intestinalis following lactulose and steroid treatment in a liver transplant patient with an intermittently enlarged scrotum.
Topics: Ammonia; Child, Preschool; Disaccharides; Humans; Lactulose; Liver Transplantation; Male; Nitrous Oxide; Pneumatosis Cystoides Intestinalis; Prednisone; Scrotum | 1987 |
In hepatic coma, the problem comes from the colon, but will the answers come from there?
Topics: Ammonia; Bacteria; Colon; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Nitrogen | 1987 |
Nitrogen in fecal bacterial, fiber, and soluble fractions of patients with cirrhosis: effects of lactulose and lactulose plus neomycin.
Topics: Aged; Ammonia; Bacteria; Disaccharides; Feces; Gastrointestinal Motility; Humans; Lactulose; Male; Middle Aged; Neomycin; Nitrogen; Urea | 1987 |
[Therapy of portosystemic encephalopathy].
Topics: Amino Acids, Branched-Chain; Ammonia; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Neomycin | 1986 |
[Ammonia and glutamine metabolism of the intestine. The effect of lactulose and neomycin].
Topics: Ammonia; Animals; Bacteria, Aerobic; Bacteria, Anaerobic; Diarrhea; Disaccharides; Germ-Free Life; Glutamine; In Vitro Techniques; Intestinal Mucosa; Intestines; Lactulose; Neomycin; Rats | 1986 |
Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
Topics: Adult; Ammonia; Cerebrovascular Circulation; Chronic Disease; Disaccharides; Electroencephalography; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Patient Acceptance of Health Care; Psychological Tests; Sugar Alcohols; Time Factors; Veins | 1985 |
[Ambulatory diagnosis and therapy control of portasystemic encephalopathy in patients with liver cirrhosis].
Topics: Aged; Ammonia; Female; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neomycin; Neuropsychological Tests; Psychomotor Performance; Reaction Time; Tremor | 1985 |
Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
Topics: Ammonia; Blood Urea Nitrogen; Brain Diseases; Chlorides; Chronic Disease; Disaccharides; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Liver Cirrhosis; Liver Function Tests; Neomycin; Potassium; Sodium | 1974 |
Hepatic encephalopathy.
Topics: Acetaminophen; Ammonia; Animals; Brain; Brain Edema; Diet Therapy; Dopamine; Female; Humans; Lactulose; Liver Diseases; Liver Transplantation; Male; Neomycin; Nervous System Diseases; Parabiosis; Renal Dialysis; Serotonin; Suicide; Swine; Tryptophan | 1973 |
[Correction by L-dopa of neurologic manifestations of a chronic portocaval encephalopathy].
Topics: Alcoholism; Ammonia; Brain Diseases; Dihydroxyphenylalanine; Electroencephalography; Humans; Ketoglutaric Acids; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neurologic Manifestations; Ornithine; Prednisone; Silicosis; Tremor | 1972 |
Lactulose enemas.
Topics: Ammonia; Child; Dehydration; Disaccharides; Enema; Fructose; Humans; Lactulose; Metabolic Diseases | 1973 |
Lactulose in the treatment of acute hepatic encephalopathy.
Topics: Acute Disease; Ammonia; Connecticut; Dietary Proteins; Evaluation Studies as Topic; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Nitrogen | 1973 |
Increased nitrogen removal from the intestinal tract of uraemic patients.
Topics: Adolescent; Adult; Aged; Ammonia; Blood Urea Nitrogen; Dietary Proteins; Feces; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Lactulose; Middle Aged; Nitrogen; Starch; Uremia | 1973 |
Milk protein in the treatment of chronic portasystemic encephalopathy. A long-term study of therapeutic measures in a patient with chronic porta-systemic encephalopathy.
Topics: Aged; Ammonia; Animals; Chronic Disease; Diet Therapy; Dogs; Electroencephalography; Hepatic Encephalopathy; Humans; Lactose; Lactulose; Male; Milk Proteins; Neomycin; Portal System | 1974 |
Hepatic encephalopathy.
Topics: Amino Acids; Ammonia; Bromocriptine; Constipation; Dietary Proteins; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Infections; Kidney Diseases; Lactulose; Levodopa; Liver Diseases; Neomycin; Neurotransmitter Agents | 1981 |
Treatment of adult-type citrullinemia with administration of citrate.
Topics: Amino Acids; Ammonia; Circadian Rhythm; Citrates; Citric Acid; Citrulline; Glutamates; Glutamic Acid; Humans; Lactulose; Male; Middle Aged; Urea | 1981 |
[Diagnosis and treatment of hyperazotemia in liver cirrhosis].
Topics: Ammonia; Drug Therapy, Combination; Female; Humans; Lactulose; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Ornithine; Uremia | 1983 |
Pulmonary hydrogen and methane and plasma ammonia after the administration of lactulose or sorbitol.
Topics: Adult; Ammonia; Breath Tests; Disaccharides; Female; Fermentation; Humans; Hydrogen; Intestinal Mucosa; Intestines; Lactulose; Liver Cirrhosis; Male; Methane; Middle Aged; Sorbitol | 1983 |
Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects.
Topics: Aged; Ammonia; Disaccharides; Drug Interactions; Drug Therapy, Combination; Feces; Humans; Intestinal Mucosa; Lactulose; Liver Cirrhosis, Alcoholic; Middle Aged; Neomycin; Nitrogen; Urea | 1982 |
Portosystemic encephalopathy in two young dogs: some additional diagnostic and therapeutic considerations.
Topics: Ammonia; Animals; Brain Diseases; Dog Diseases; Dogs; Female; Lactulose; Male; Portal Vein | 1981 |
Ammonia production by intestinal bacteria: the effects of lactose, lactulose and glucose.
Topics: Amino Acids; Ammonia; Bacteria; Bacteroidaceae; Carbohydrate Metabolism; Enterobacteriaceae; Fermentation; Glucose; Hydrogen-Ion Concentration; Intestines; Lactose; Lactulose | 1980 |
[Bifidum-milk and lactulose in the therapy of chronic liver diseases].
Topics: Ammonia; Child; Disaccharides; Female; Humans; Lactobacillus; Lactulose; Liver Cirrhosis; Liver Diseases; Phenols | 1980 |
[The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs].
Topics: Amino Acids; Ammonia; Animals; Disease Models, Animal; Dogs; Hepatic Encephalopathy; Lactulose; Male; Portacaval Shunt, Surgical; Sugar Alcohols | 1995 |
Mechanism for lowering blood ammonia levels by lactitol.
Topics: Acetates; Administration, Oral; Ammonia; Animals; Cecum; Charcoal; Colon; Disease Models, Animal; Gastrointestinal Transit; Hydrogen-Ion Concentration; Intestinal Absorption; Intestine, Small; Lactulose; Male; Portal Vein; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Sugar Alcohols | 1995 |
[Effect of lactitol (NS-4) on the increase in blood and brain ammonia concentration and on coma in newly developed rat models of hepatic coma].
Topics: Ammonia; Animals; Brain; Disease Models, Animal; Hepatic Encephalopathy; Lactulose; Male; Rats; Rats, Sprague-Dawley; Sugar Alcohols | 1995 |
Lactulose or paromomycin do not affect ammonia generation in the isolated perfused rat small intestine.
Topics: Amino Acids; Ammonia; Animals; Glutamine; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Lactulose; Male; Paromomycin; Perfusion; Rats; Rats, Sprague-Dawley | 1994 |
Hyperammonemia after chemotherapy in an adolescent with hepatocellular carcinoma.
Topics: Adolescent; Ammonia; Antineoplastic Combined Chemotherapy Protocols; Arginine; Brain Diseases; Carcinoma, Hepatocellular; Female; Humans; Lactulose; Neomycin; Parenteral Nutrition, Total; Renal Dialysis | 1997 |
Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.
Topics: Adult; Aged; Ammonia; Female; Helicobacter Infections; Helicobacter pylori; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Psychometrics | 1999 |
[Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
Topics: Ammonia; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin | 2000 |
Intestinal effects of mannanoligosaccharides, transgalactooligosaccharides, lactose and lactulose in dogs.
Topics: Amino Acids; Ammonia; Animals; Diarrhea; Dog Diseases; Dogs; Feces; Female; Hydrogen-Ion Concentration; Intestines; Lactose; Lactulose; Mannans; Oligosaccharides; Water | 2002 |
Lactulose-induced diarrhoea in rats: effects on caecal development and activities of microbial enzymes.
Topics: Ammonia; Animals; Cecum; Diarrhea; Dietary Carbohydrates; Fatty Acids, Volatile; Glucuronidase; Humans; Lactulose; Male; Rats; Rats, Wistar | 2002 |
Probiotics can treat hepatic encephalopathy.
Topics: Ammonia; Anti-Bacterial Agents; Digestive System; Hepatic Encephalopathy; Humans; Lactulose; Models, Biological; Probiotics | 2003 |
[Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain].
Topics: Ammonia; Clinical Trials as Topic; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Quality of Life; Self-Help Groups | 2004 |
Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy.
Topics: Ammonia; Anti-Bacterial Agents; Clinical Trials as Topic; Hepatic Encephalopathy; Humans; Intestinal Mucosa; Intestines; Lactulose; Models, Biological; Probiotics; Treatment Outcome | 2005 |
Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.
Topics: Ammonia; Animals; Endotoxins; Gastrointestinal Agents; Hepatic Encephalopathy; Incidence; Lactulose; Liver; Liver Function Tests; Male; Probiotics; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Thioacetamide | 2005 |
Neostigmine for the treatment of acute hepatic encephalopathy with acute intestinal pseudo-obstruction in a cirrhotic patient.
Topics: Air; Ammonia; Blood Pressure; Cholinesterase Inhibitors; Electrolytes; Enema; Fibrosis; Hepatic Encephalopathy; Humans; Intestinal Pseudo-Obstruction; Lactulose; Liver; Male; Middle Aged; Neostigmine; Peristalsis; Polyethylene Glycols; Radiography; Time Factors | 2005 |
Use of the in vitro cumulative gas production technique for pigs: an examination of alterations in fermentation products and substrate losses at various time points.
Topics: Ammonia; Animal Feed; Animals; Beta vulgaris; Bioreactors; Fatty Acids, Volatile; Feces; Fermentation; Gases; Inulin; Lactulose; Starch; Swine; Time Factors; Triticum | 2006 |
[Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].
Topics: Adult; Aged; Ammonia; Confusion; Diagnosis, Differential; Electroencephalography; Fatal Outcome; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver; Male; Middle Aged; Treatment Outcome | 2007 |
Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents.
Topics: Acute Disease; Alanine; Ammonia; Animals; Carbon Tetrachloride; Chronic Disease; Disease Models, Animal; Hyperammonemia; Lactobacillus plantarum; Lactulose; Liver Failure; Male; Mice; Mice, Inbred C57BL; Probiotics; Rats; Rats, Inbred Lew; Thioacetamide | 2008 |
Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Topics: Adult; Ammonia; Event-Related Potentials, P300; Female; Flicker Fusion; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Psychometrics; Sodium | 2009 |
Gut flora and hepatic encephalopathy in patients with cirrhosis.
Topics: Ammonia; Anti-Infective Agents; Gastrointestinal Agents; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifamycins; Rifaximin; Secondary Prevention | 2010 |
Peripheral ammonia as a mediator of methamphetamine neurotoxicity.
Topics: Alanine Transaminase; Ammonia; Analysis of Variance; Animals; Aspartate Aminotransferases; Benzodiazepines; Biogenic Monoamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Fever; Gene Expression Regulation; Lactulose; Liver Diseases; Male; Mass Spectrometry; Methamphetamine; Microdialysis; Neuroprotective Agents; Neurotoxicity Syndromes; Rats; Rats, Sprague-Dawley; Time Factors | 2012 |
Effects of cyclophosphamide and lactulose on the release of ammonia and medium-molecular-weight substances from the intestine into blood in rats.
Topics: Ammonia; Animals; Cyclophosphamide; Intestinal Mucosa; Intestines; Lactulose; Male; Methylene Blue; Molecular Weight; Rats | 2013 |
Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity.
Topics: Ammonia; Animals; Aspartic Acid; Body Temperature; Brain; Calpain; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Administration Routes; Glial Fibrillary Acidic Protein; Glutamic Acid; Lactulose; Male; Methamphetamine; Molecular Weight; Rats; Rats, Sprague-Dawley; Spectrin; Time Factors | 2014 |
[Reversible hepatic myelopathy: a case report].
Topics: Administration, Oral; Adult; Ammonia; Biomarkers; Evoked Potentials, Somatosensory; Female; Gastrointestinal Agents; Humans; Hyperammonemia; Lactulose; Liver Cirrhosis, Alcoholic; Liver Transplantation; Spinal Cord Diseases; Tibia; Treatment Outcome | 2014 |
[Hepatic encephalopathy. Early therapy is most important!].
Topics: Ammonia; Anti-Bacterial Agents; Early Diagnosis; Early Medical Intervention; Hepatic Encephalopathy; Humans; Lactulose; Life Style | 2014 |
Bispectral index monitoring for diagnosis and assessment of severity of hepatic encephalopathy in cirrhotic patients.
Topics: Adult; Ammonia; Case-Control Studies; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Psychometrics; ROC Curve; Severity of Illness Index | 2015 |
[In Process Citation].
Topics: Ammonia; Clinical Trials as Topic; Dipeptides; Early Diagnosis; Early Medical Intervention; Evidence-Based Medicine; Hepatic Encephalopathy; Humans; Lactulose; Prognosis; Rifamycins; Rifaximin | 2015 |
Peripheral ammonia and blood brain barrier structure and function after methamphetamine.
Topics: Ammonia; Animals; Blood-Brain Barrier; Capillaries; Capillary Permeability; Central Nervous System Stimulants; Cerebral Cortex; Claudin-5; Disease Models, Animal; Fever; Gastrointestinal Agents; Lactulose; Male; Matrix Metalloproteinase 9; Methamphetamine; Occludin; Rats, Sprague-Dawley | 2016 |
A new measurement protocol to differentiate sources of halitosis.
Topics: Adult; Ammonia; Cyclohexanols; Cysteine; Eucalyptol; Female; Halitosis; Humans; Hydrogen; Hydrogen Sulfide; Lactulose; Lung Diseases; Male; Menthol; Middle Aged; Monoterpenes; Mouth Diseases; Nasal Cavity; Nose Diseases; Pulmonary Alveoli; Sulfur Dioxide; Volatile Organic Compounds; Young Adult | 2016 |
Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy.
Topics: Aged; Ammonia; Bacterial Translocation; Biomarkers; Cognition; DNA, Bacterial; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Psychometrics; Severity of Illness Index; Spain | 2017 |
Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
Topics: Adult; Ammonia; Disorders of Excessive Somnolence; Female; Flicker Fusion; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Polysomnography; Psychometrics; Quality of Life; Sleep Wake Disorders; Treatment Outcome | 2017 |
Anti-ammonia treatment-responsive myoclonus as initial presentation of acquired hepatocerebral degeneration.
Topics: Ammonia; Dipeptides; Female; Hepatolenticular Degeneration; Humans; Lactulose; Middle Aged; Myoclonus | 2018 |
Dose-Dependent Prebiotic Effect of Lactulose in a Computer-Controlled In Vitro Model of the Human Large Intestine.
Topics: Acetates; Adult; Ammonia; Bifidobacterium; Body Mass Index; Butyrates; Computer Simulation; DNA, Bacterial; Dose-Response Relationship, Drug; Fatty Acids, Volatile; Female; Gastrointestinal Microbiome; Humans; Hydrogen-Ion Concentration; Intestine, Large; Lactic Acid; Lactobacillus; Lactulose; Male; Models, Biological; Prebiotics; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2017 |
Lactulose decreases neuronal activation and attenuates motor behavioral deficits in hyperammonemic rats.
Topics: Ammonia; Animals; Aquaporin 4; Aspartate Aminotransferases; Behavior, Animal; Bilirubin; Creatinine; Disease Models, Animal; Hyperammonemia; Lactulose; Liver; Male; Motor Activity; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar | 2017 |
Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials.
Topics: Acetylcarnitine; Adult; Ammonia; Dipeptides; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Network Meta-Analysis; Neuroprotective Agents; Probiotics; Randomized Controlled Trials as Topic; Rifaximin; Serum Albumin; Treatment Outcome | 2018 |
Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis.
Topics: Ammonia; Biomarkers; Disease Management; Female; Follow-Up Studies; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Inpatients; Lactulose; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2020 |
In vitro assessment of prebiotic properties of xylooligosaccharides produced by Bacillus subtilis 3610.
Topics: Adult; Ammonia; Bacillus subtilis; Carbon Dioxide; Fatty Acids, Volatile; Feces; Female; Gastrointestinal Microbiome; Glucuronates; Humans; Hydrogen; Hydrogen-Ion Concentration; Lactic Acid; Lactulose; Male; Oligosaccharides; Polysaccharides, Bacterial; Prebiotics | 2020 |
Hyperammonemic Encephalopathy Exacerbated by Parenteral Nutrition in Fibrolamellar Hepatocellular Carcinoma.
Topics: Adult; Ammonia; Brain Diseases; Carcinoma, Hepatocellular; Female; Gastrointestinal Agents; Humans; Hyperammonemia; Lactulose; Liver Neoplasms; Parenteral Nutrition, Total; Rifaximin | 2020 |
Use of Lactulose to Treat Hyperammonemia in ICU Patients Without Chronic Liver Disease or Significant Hepatocellular Injury.
Topics: Adult; Ammonia; Carcinoma, Hepatocellular; Humans; Hyperammonemia; Intensive Care Units; Lactulose; Liver Neoplasms | 2022 |
Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy.
Topics: Ammonia; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifamycins; Rifaximin | 2023 |
The clinical value of breath ammonia determination in patients with irritable bowel syndrome.
Topics: Ammonia; Bacteria; Breath Tests; Humans; Hydrogen; Irritable Bowel Syndrome; Lactulose; Rifaximin | 2022 |
Ammonia - an enduring foe - What evaluating whole body ammonia metabolism can teach us about cirrhosis and therapies treating hepatic encephalopathy.
Topics: Ammonia; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifamycins; Rifaximin | 2023 |